News & Events

Industry News

• Acelity: Files Registration Statement for Proposed Initial Public Offering
• 26/08/2015
• 
           SAN ANTONIO, August 26, 2015 - Acelity Holdings, Inc. (“Acelity”) today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Acelity is a wholly-owned subsidiary of Acelity L.P. Inc., and in connection with this offering, Acelity will become the parent company of Acelity L.P. Inc.’s advanced wound care and regenerative medicine businesses.
           J.P. Morgan, Goldman, Sachs & Co. and BofA Merrill Lynch are acting as joint book-running managers for the proposed offering. The offering will be made only by means of a prospectus.
  
  

  	Company Name	ACELITY HOLDINGS, INC.
  	Company Address	12390 WEST INTERSTATE 10, SAN ANTONIO, TX 78249
  	Company Phone	210-524-9000
  	Company Website	www.acelity.com
  	CEO	Joseph F. Woody
  	Employees (as of 12/31/2014)	5700
  	State of Inc	TX
  	Fiscal Year End	12/31
  	Status	Filed (8/26/2015)
  	Exchange	New York Stock Exchange
  	Offer Amount	$1,000,000,000.00
  	Lockup Period (days)	180
  	CIK	0001651347